Luis Querol Selected Research

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

6/2022	Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
11/2021	European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
1/2021	Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
1/2021	European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision.
1/2021	Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice.
1/2021	Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome.
1/2021	Serum Contactin-1 in CIDP: A Cross-Sectional Study.
10/2019	Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
1/2019	Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
1/2019	Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis Querol Research Topics

Disease

24	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 03/2013
9	Myasthenia Gravis 01/2022 - 10/2013
8	Polyneuropathies (Polyneuropathy) 01/2019 - 03/2013
6	Tremor (Tremors) 06/2022 - 03/2014
4	Ataxia (Dyssynergia) 06/2022 - 09/2018
4	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 03/2014
4	Thymoma (Thymic Carcinoma) 01/2021 - 01/2014
4	Multiple Sclerosis 01/2019 - 06/2013
4	Autoimmune Diseases (Autoimmune Disease) 09/2017 - 06/2013
3	Guillain-Barre Syndrome 11/2021 - 11/2020
2	Neuralgia (Stump Neuralgia) 11/2021 - 01/2021
2	Pain (Aches) 11/2021 - 01/2021
2	Neoplasms (Cancer) 05/2018 - 09/2017
1	COVID-19 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Infections 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Neuroblastoma 11/2021
1	Hypertrophy 06/2021
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Paralysis (Palsy) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2019
1	Disease Progression 09/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Dysferlinopathy 10/2018
1	Paraneoplastic Polyneuropathy 05/2018
1	Nervous System Diseases (Neurological Disorders) 05/2018
1	Gait Ataxia 01/2016
1	Clinical Deterioration 01/2016
1	Muscle Weakness 10/2014
1	Muscular Diseases (Myopathy) 07/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2014
1	Polyradiculoneuropathy (Polyradiculoneuritis) 03/2014
1	Atherosclerosis 11/2013
1	Stroke (Strokes) 11/2013
1	Ischemic Stroke 11/2013
1	Epstein-Barr Virus Infections 09/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2013

Drug/Important Bio-Agent (IBA)

23	AntibodiesIBA 06/2022 - 03/2013
18	AutoantibodiesIBA 06/2022 - 06/2013
10	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2013
10	Immunoglobulin G (IgG)IBA 01/2022 - 09/2013
9	Intravenous Immunoglobulins (IVIG)FDA Link 11/2021 - 12/2013
7	Rituximab (Mabthera)FDA Link 01/2022 - 10/2013
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
6	AntigensIBA 05/2018 - 03/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 10/2015
4	Cholinergic ReceptorsIBA 01/2021 - 01/2014
3	Pharmaceutical PreparationsIBA 11/2021 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 09/2013
2	GangliosidesIBA 06/2022 - 11/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021 - 01/2021
2	Anti-Idiotypic AntibodiesIBA 11/2021 - 04/2018
2	Contactin 1IBA 01/2021 - 03/2014
2	Immunoglobulin M (IgM)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2016
2	muskIBA 06/2016 - 01/2016
2	CortactinIBA 01/2016 - 10/2014
2	AutoantigensIBA 09/2013 - 06/2013
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	GadoliniumIBA 06/2021
1	COVID-19 VaccinesIBA 01/2021
1	CytokinesIBA 01/2020
1	Complement System Proteins (Complement)IBA 10/2019
1	human GAA protein (Myozyme)FDA Link 09/2019
1	Myelin-Associated GlycoproteinIBA 01/2019
1	Interferon-betaIBA 01/2019
1	InterferonsIBA 01/2019
1	PerforinIBA 01/2019
1	DysferlinIBA 10/2018
1	Cell Adhesion MoleculesIBA 05/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2017
1	Protein Isoforms (Isoforms)IBA 07/2017
1	Potassium Channels (Potassium Channel)IBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	Nucleic AcidsIBA 07/2014
1	Polysaccharides (Glycans)IBA 03/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2013
1	erucylphosphocholineIBA 11/2013
1	Biological ProductsIBA 10/2013
1	eculizumab FDA Link 10/2013

Therapy/Procedure

4	Immunotherapy 01/2022 - 10/2013
3	Therapeutics 04/2018 - 03/2013
2	Plasma Exchange 11/2021 - 01/2021